Publication: Promoting quality use of medicines in South-East Asia: Reports from country situational analyses
Issued Date
2018-07-05
Resource Type
ISSN
14726963
Other identifier(s)
2-s2.0-85049592319
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
BMC Health Services Research. Vol.18, No.1 (2018)
Suggested Citation
Kathleen Anne Holloway, Anita Kotwani, Gitanjali Batmanabane, Budiono Santoso, Sauwakon Ratanawijitrasin, David Henry Promoting quality use of medicines in South-East Asia: Reports from country situational analyses. BMC Health Services Research. Vol.18, No.1 (2018). doi:10.1186/s12913-018-3333-1 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/46512
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Promoting quality use of medicines in South-East Asia: Reports from country situational analyses
Abstract
© 2018 The Author(s). Background: Irrational use of medicines is widespread in the South-East Asia Region (SEAR), where policy implementation to encourage quality use of medicines (QUM) is often low. The aim was to determine whether public-sector QUM is better in SEAR countries implementing essential medicines (EM) policies than in those not implementing them. Methods: Data on six QUM indicators and 25 EM policies were extracted from situational analysis reports of 20 country (2-week) visits made during 2010-2015. The average difference (as percent) for the QUM indicators between countries implementing versus not implementing specific policies was calculated. Policies associated with better (> 1%) QUM were included in regression of a composite QUM score versus total number of policies implemented. Results: Twenty-two policies were associated with better (> 1%) QUM. Twelve policies were associated with 3.6-9.5% significantly better use (p < 0.05), namely: standard treatment guidelines; formulary; a government unit to promote QUM; continuing health worker education on prescribing by government; limiting over-the-counter (OTC) availability of systemic antibiotics; disallowing public-sector prescriber revenue from medicines sales; not charging fees at the point of care; monitoring advertisements of OTC medicines; public education on QUM; and a good drug supply system. There was significant correlation between the number of policies implemented out of 22 and the composite QUM score (r = 0.71, r2 = 0.50, p < 0.05). Conclusions: Country situational analyses allowed rapid data collection that showed EM policies are associated with better QUM. SEAR countries should implement all such policies.